These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6542055)

  • 21. [Mechanism of action of ochratoxin A, probable agent of endemic Balkan nephropathy].
    Dirheimer G; Röschenthaler R; Creppy E
    Bull Acad Natl Med; 1983 Jan; 167(1):67-74. PubMed ID: 6196096
    [No Abstract]   [Full Text] [Related]  

  • 22. Retinol, ascorbic acid and alpha-tocopherol prevent DNA adduct formation in mice treated with the mycotoxins ochratoxin A and zearalenone.
    Grosse Y; Chekir-Ghedira L; Huc A; Obrecht-Pflumio S; Dirheimer G; Bacha H; Pfohl-Leszkowicz A
    Cancer Lett; 1997 Mar; 114(1-2):225-9. PubMed ID: 9103298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ochratoxin a causes DNA damage and cytogenetic effects but no DNA adducts in rats.
    Mally A; Pepe G; Ravoori S; Fiore M; Gupta RC; Dekant W; Mosesso P
    Chem Res Toxicol; 2005 Aug; 18(8):1253-61. PubMed ID: 16097798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic properties of pure overproduced Bacillus subtilis phenylalanyl-tRNA synthetase do not favour its in vivo inhibition by ochratoxin A.
    Roth A; Eriani G; Dirheimer G; Gangloff J
    FEBS Lett; 1993 Jul; 326(1-3):87-91. PubMed ID: 8325392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinico-pathomorphological, serum biochemical and histological studies in broilers fed ochratoxin A and a toxin deactivator (Mycofix Plus).
    Hanif NQ; Muhammad G; Siddique M; Khanum A; Ahmed T; Gadahai JA; Kaukab G
    Br Poult Sci; 2008 Sep; 49(5):632-42. PubMed ID: 18836911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations induced in vitro by ochratoxin A in rat lymphoid cells.
    Alvarez-Erviti L; Leache C; González-Peñas E; de Cerain AL
    Hum Exp Toxicol; 2005 Sep; 24(9):459-66. PubMed ID: 16235735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats.
    Kamp HG; Eisenbrand G; Janzowski C; Kiossev J; Latendresse JR; Schlatter J; Turesky RJ
    Mol Nutr Food Res; 2005 Dec; 49(12):1160-7. PubMed ID: 16302199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of two metabolites of ochratoxin A, (4R)-4-hydroxyochratoxin A and ochratoxin alpha, on immune response in mice.
    Creppy EE; Størmer FC; Röschenthaler R; Dirheimer G
    Infect Immun; 1983 Mar; 39(3):1015-8. PubMed ID: 6341224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue distribution of radioactivity from ochratoxin A-14C in rats.
    Lillehoj EB; Kwolek WF; Elling F; Krogh P
    Mycopathologia; 1979 Sep; 68(3):175-7. PubMed ID: 530296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ochratoxin A-binding proteins in rat organs and plasma and in different cell lines of the kidney.
    Schwerdt G; Freudinger R; Silbernagl S; Gekle M
    Toxicology; 1999 Jul; 135(1):1-10. PubMed ID: 10454219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cells.
    Grosse Y; Baudrimont I; Castegnaro M; Betbeder AM; Creppy EE; Dirheimer G; Pfohl-Leszkowicz A
    Chem Biol Interact; 1995 Mar; 95(1-2):175-87. PubMed ID: 7697749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of protein synthesis in Streptococcus faecalis by ochratoxin A.
    Heller K; Röschenthaler
    Can J Microbiol; 1978 Apr; 24(4):467-72. PubMed ID: 205331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for an enterohepatic circulation of ochratoxin A in mice.
    Roth A; Chakor K; Creppy EE; Kane A; Roschenthaler R; Dirheimer G
    Toxicology; 1988 Mar; 48(3):293-308. PubMed ID: 3344528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of ochratoxin A on ER stress, MAPK signaling pathway and autophagy of kidney and spleen in pigs.
    Gan F; Hou L; Zhou Y; Liu Y; Huang D; Chen X; Huang K
    Environ Toxicol; 2017 Oct; 32(10):2277-2286. PubMed ID: 28699257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes of renal mRNA species abundance by ochratoxin A.
    Meisner H; Polsinelli L
    Biochem Pharmacol; 1986 Feb; 35(4):661-5. PubMed ID: 3753873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of COX-2 and hsp72 in peritoneal macrophages after an acute ochratoxin A treatment in mice.
    Ferrante MC; Bilancione M; Raso GM; Esposito E; Iacono A; Zaccaroni A; Meli R
    Life Sci; 2006 Aug; 79(13):1242-7. PubMed ID: 16643956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total synthesis and cytotoxicity evaluation of all ochratoxin A stereoisomers.
    Cramer B; Harrer H; Nakamura K; Uemura D; Humpf HU
    Bioorg Med Chem; 2010 Jan; 18(1):343-7. PubMed ID: 19919898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of renal gluconeogenesis in rats by ochratoxin.
    Meisner H; Selanik P
    Biochem J; 1979 Jun; 180(3):681-4. PubMed ID: 486143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A.
    Pfohl-Leszkowicz A; Grosse Y; Kane A; Creppy EE; Dirheimer G
    Mutat Res; 1993 Oct; 289(2):265-73. PubMed ID: 7690895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of ochratoxin A toxicity in mice treated with phenylalanine and phenobarbital.
    Moroi K; Suzuki S; Kuga T; Yamazaki M; Kanisawa M
    Toxicol Lett; 1985 Apr; 25(1):1-5. PubMed ID: 3992601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.